Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Decima Health's Weir to pitch eczema treatment

Tuesday 05 April 2016 04:39 PM

Decima Health's Weir to pitch eczema treatment at Chicago dermatology conference

By Jonathan Underhill

April 5 (BusinessDesk) - Iona Weir, chief executive of Auckland-based Decima Health, will get the chance to pitch the eczema treatment she developed to a global dermatology conference in the US after organisers liked her abstract so much they asked her to be a keynote speaker.

Weir will address the International Conference on Clinical and Experimental Dermatology in Chicago in May about Atopsis, a product that grew out of her Ph.D. in 1997 on programmed cell death in plants known as apoptosis.

Her research showed apoptosis in plants was reversible, unlike in animals, and she was able to extract "critical reactions" in plants that could be put in a cream as a topical application for skin conditions in humans, such as eczema and acne. The extract encourages the body's immune response to attack affected areas and repair damaged cells.

"By manipulating this reversibility in plants I have been able to create Atopsis to manipulate apoptosis and immune function in human cells to stimulate cell repair and growth," Weir said. Clinical trials in the US and New Zealand both showed a reduction in the symptoms of eczema, opening the door for a larger US study, she said.

Weir won an international award for her original Ph.D. and was able to continue her research with a grant from the Marsden Fund. A grant from Callaghan Innovation helped fund the double blind placebo controlled clinical trial completed by Southern Clinical Trials Group at the end of 2015.

Decima has set up a subsidiary, Bionona, to pursue global partnerships for the release of Atopsis. Bionona is chaired by Paul Dallimore, former executive chairman of National Property Trust and chair of Highgate Group.

(BusinessDesk receives funding to help cover the commercialisation of innovation from Callaghan Innovation.)

(BusinessDesk)

ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Ground Rules: Government Moves To Protect Best Growing Land

“Continuing to grow food in the volumes and quality we have come to expect depends on the availability of land and the quality of the soil. Once productive land is built on, we can’t use it for food production, which is why we need to act now.” More>>

ALSO:

Royal Society: Calls For Overhaul Of Gene-Technology Regulations

An expert panel considering the implications of new technologies that allow much more controlled and precise ‘editing’ of genes, has concluded it’s time for an overhaul of the regulations and that there’s an urgent need for wide discussion and debate about gene editing... More>>

ALSO:

Retail: Card Spending Dips In July

Seasonally-adjusted electronic card spending dipped in July by 0.1 percent after being flat in June, according to Stats NZ. Economists had expected a 0.5 percent lift, according to the median in a Bloomberg poll. More>>

ALSO:

Product Stewardship: Govt Takes More Action To Reduce Waste

The Government is proposing a new way to deal with environmentally harmful products before they become waste, including plastic packing and bottles, as part of a wider plan to reduce the amount of rubbish ending up in landfills. More>>

ALSO:

Earnings Update: Fonterra Sees Up To $675m Loss On Writedowns

“While the Co-op’s FY19 underlying earnings range is within the current guidance of 10-15 cents per share, when you take into consideration these likely write-downs, we expect to make a reported loss of $590-675 million this year, which is a 37 to 42 cent loss per share." More>>

ALSO: